Literature DB >> 3005225

The alveolar macrophage.

A O Fels, Z A Cohn.   

Abstract

The alveolar macrophage is one of the few tissue macrophage populations readily accessible to study both in the human and in animals. Since harvesting of these cells by bronchoalveolar lavage was first described in 1961, alveolar macrophages have been extensively investigated. This population is the predominant cell type within the alveolus, and undoubtedly serves as the first line of host defense against inhaled organisms and soluble and particulate molecules. Early studies focussed on this endocytic role and delineated the cells' phagocytic and microbicidal capacities. More recent investigations demonstrated an extensive synthetic and secretory repertoire including lysozyme, neutral proteases, acid hydrolases and O2 metabolites. In addition, the complex immunoregulatory role of the macrophage has also been appreciated. These cells have been shown to produce a wide variety of pro- and anti-inflammatory agents including arachidonic acid metabolites of the cyclooxygenase and lipoxygenase pathways, cytokines which modulate lymphocyte function and factors which promote fibroblast migration and replication.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3005225     DOI: 10.1152/jappl.1986.60.2.353

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  105 in total

Review 1.  Role of leukotrienes in antimicrobial host defense of the lung.

Authors:  M Peters-Golden; M Coffey
Journal:  Clin Rev Allergy Immunol       Date:  1999 Spring-Summer       Impact factor: 8.667

2.  Localization of epidermal-type fatty acid binding protein in alveolar macrophages and some alveolar type II epithelial cells in mouse lung.

Authors:  Y Owada; S A Abdelwahab; R Suzuki; H Iwasa; H Sakagami; F Spener; H Kondo
Journal:  Histochem J       Date:  2001-08

Review 3.  In vitro study of gas effects on alveolar macrophages.

Authors:  B Wallaert; C Voisin
Journal:  Cell Biol Toxicol       Date:  1992 Jul-Sep       Impact factor: 6.691

4.  Is the function of alveolar macrophages altered following blunt chest trauma?

Authors:  Ulrich C Liener; Mario Perl; Markus S Huber-Lang; Daniel H Seitz; Uwe B Brückner; Florian Gebhard; Markus W Knöferl
Journal:  Langenbecks Arch Surg       Date:  2011-02       Impact factor: 3.445

Review 5.  Group XV phospholipase A₂, a lysosomal phospholipase A₂.

Authors:  James A Shayman; Robert Kelly; Jessica Kollmeyer; Yongqun He; Akira Abe
Journal:  Prog Lipid Res       Date:  2010-11-11       Impact factor: 16.195

6.  Oxidants spontaneously released by alveolar macrophages of cigarette smokers can inactivate the active site of alpha 1-antitrypsin, rendering it ineffective as an inhibitor of neutrophil elastase.

Authors:  R C Hubbard; F Ogushi; G A Fells; A M Cantin; S Jallat; M Courtney; R G Crystal
Journal:  J Clin Invest       Date:  1987-11       Impact factor: 14.808

7.  Low-level laser therapy (LLLT) acts as cAMP-elevating agent in acute respiratory distress syndrome.

Authors:  Flávia Mafra de Lima; Leonardo M Moreira; A B Villaverde; Regiane Albertini; Hugo C Castro-Faria-Neto; Flávio Aimbire
Journal:  Lasers Med Sci       Date:  2010-12-24       Impact factor: 3.161

8.  Respiratory syncytial virus induces interleukin-10 by human alveolar macrophages. Suppression of early cytokine production and implications for incomplete immunity.

Authors:  J R Panuska; R Merolla; N A Rebert; S P Hoffmann; P Tsivitse; N M Cirino; R H Silverman; J A Rankin
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

9.  Mouse hepatitis virus strain UAB infection enhances resistance to Salmonella typhimurium in mice by inducing suppression of bacterial growth.

Authors:  M T Fallon; W H Benjamin; T R Schoeb; D E Briles
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

10.  NADPH oxidase limits lipopolysaccharide-induced lung inflammation and injury in mice through reduction-oxidation regulation of NF-κB activity.

Authors:  Wei Han; Hui Li; Jiyang Cai; Linda A Gleaves; Vasiliy V Polosukhin; Brahm H Segal; Fiona E Yull; Timothy S Blackwell
Journal:  J Immunol       Date:  2013-03-25       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.